Promising AUD drug trial halted early
NCT ID NCT06648655
First seen Apr 14, 2026 · Last updated Apr 28, 2026 · Updated 1 time
Summary
This study tested a new drug, TMP-301, to see if it could help people with alcohol use disorder drink less. The trial was stopped early, so results are limited. About 110 adults were expected to join, but the study did not complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
CNS Healthcare
Orlando, Florida, 32801, United States
-
CNS Healthcare- Jacksonville South
Jacksonville, Florida, 32256, United States
-
CenExcel iResearch
Decatur, Georgia, 30030, United States
-
CenExcel iResearch
Savannah, Georgia, 31405, United States
-
DelRicht Research - Murphy Clinic
Mandeville, Louisiana, 70448, United States
-
Headlands Research
Scottsdale, Arizona, 85260, United States
-
IMA Clinical Research
Albuquerque, New Mexico, 87109, United States
-
Medical University of South Carolina, Institute of Psychiatry
Charleston, South Carolina, 29425, United States
-
Neurobehavioral Research, Inc.
Cedarhurst, New York, 11516, United States
-
Research Centers of America, LLC
Hollywood, Florida, 33024, United States
-
Segal Trials - West Broward Outpatient Site
Lauderhill, Florida, 33311, United States
-
University of Virginia: Center for Leading Edge Addiction Research
Charlottesville, Virginia, 22903, United States
-
Yale School of Medicine
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.